No shock for USCOM
Wednesday, 08 October, 2008
Medical device company USCOM (ASX: USC) has reported that its USCOM 1A device improves management of septic shock in children, according to research published in Pediatrics.
The research was conducted at London's Great Ormond Hospital for Sick Children.
It showed that the USCOM device, which measures cardiac output, allowed earlier and more accurate detection of abnormalities in children admitted to intensive care with septic shock.
The researchers suggested that using USCOM may be an improvement on the current septic shock practice guidelines, and could allow more appropriate prescription of dugs for treatment.
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
Females found to carry a higher genetic risk of depression
An international team of scientists has discovered about twice as many genetic 'flags'...
